Literature DB >> 5440206

Effect of additional albumin administration during exchange transfusion on plasma albumin-binding capacity.

B Wood, A Comley, J Sherwell.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 5440206      PMCID: PMC2020389          DOI: 10.1136/adc.45.239.59

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  BILIRUBIN EQUILIBRATION DURING EXCHANGE TRANSFUSION IN HEMOLYTIC DISEASE OF THE NEWBORN.

Authors:  A SPROUL; L SMITH
Journal:  J Pediatr       Date:  1964-07       Impact factor: 4.406

2.  Studies in hyperbilirubinemia. II. Clearance of bilirubin from plasma and extravascular space in newborn infants during exchange transfusion.

Authors:  A K BROWN; W W ZUELZER; A R ROBINSON
Journal:  AMA J Dis Child       Date:  1957-03

3.  The dynamic equilibrium between circulating and extravascular plasma proteins.

Authors:  D GITLIN; C A JANEWAY
Journal:  Science       Date:  1953-09-11       Impact factor: 47.728

4.  The turnover rate of serum albumin in man as measured by I131-tagged albumin.

Authors:  K STERLING
Journal:  J Clin Invest       Date:  1951-11       Impact factor: 14.808

5.  Albumin administration in exchange transfusion for hyperbilirubinaemia.

Authors:  A Comley; B Wood
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

  5 in total
  3 in total

1.  Relative roles of phototherapy and phenobarbitone in treatment of nonhaemolytic neonatal jaundice.

Authors:  Y K Wong; B S Wood
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

2.  Effect of albumin administration on phototherapy for neonatal jaundice.

Authors:  Y K Wong; G R Shuttleworth; B S Wood
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

3.  Albumin administration prevents neurological damage and death in a mouse model of severe neonatal hyperbilirubinemia.

Authors:  Simone Vodret; Giulia Bortolussi; Andrea B Schreuder; Jana Jašprová; Libor Vitek; Henkjan J Verkade; Andrés F Muro
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.